Previous observations had shown that the soluble pattern recognition receptor PTX3 binds FGF8b and inhibits the angiogenic and tumorigenic activity of androgen-regulated tumor cells in which testosterone activates a FGF8b-dependent autocrine/paracrine loop of stimulation [15]. The gene discussed is PTX3; the disease is neoplasm.